FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+12.44%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$620M
AUM Growth
+$620M
(-3.5%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-19.18%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
63
New
8
Increased
6
Reduced
34
Closed
4
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$8.32M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$5.74M |
| 3 |
Veracyte
VCYT
|
$2.92M |
| 4 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
$2.43M |
| 5 |
CLLS
Cellectis
CLLS
|
$2.15M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$70.3M |
| 2 |
NeoGenomics
NEO
|
$22.4M |
| 3 |
AtriCure
ATRC
|
$14.4M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$13.6M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$9.28M |
Sector Composition
| 1 | Healthcare | 83.6% |
| 2 | Communication Services | 3.41% |
| 3 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $56.8M | 9.17% | 3,700,927 -1,461,136 | -28% | -$22.4M |
|
2
Omnicell
OMCL
$1.5B
| $47.7M | 7.69% | 663,109 -3,000 | -0.5% | -$216K |
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $41.4M | 6.69% | 228,645 -1,076 | -0.5% | -$195K |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $36.2M | 5.84% | 2,381,146 -10,429 | -0.4% | -$159K |
|
|
5
AtriCure
ATRC
$1.84B
| $34M | 5.48% | 969,193 -411,212 | -30% | -$14.4M |
|
6
Harvard Bioscience
HBIO
$22M
| $32.9M | 5.31% | 6,270,115 +319,101 | +5% | +$1.68M |
|
7
Heron Therapeutics
HRTX
$207M
| $26.4M | 4.25% | 833,001 -3,736 | -0.4% | -$118K |
|
|
OXFD
8
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $25.9M | 4.17% | 1,594,009 +353,618 | +29% | +$5.74M |
|
9
Ionis Pharmaceuticals
IONS
$6.8B
| $25.4M | 4.1% | 492,140 -2,207 | -0.4% | -$114K |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $24M | 3.87% | 1,151,622 -5,876 | -0.5% | -$122K |
|
11
Nektar Therapeutics
NKTR
$568M
| $22.7M | 3.66% | 372,551 -1,700 | -0.5% | -$104K |
|
|
MODN
12
DELISTED
MODEL N, INC.
MODN
| $21.2M | 3.41% | 1,334,599 -5,323 | -0.4% | -$84.4K |
|
|
13
Ligand Pharmaceuticals
LGND
$3.15B
| $20M | 3.23% | 73,020 -49,443 | -40% | -$13.6M |
|
|
CSII
14
DELISTED
Cardiovascular Systems, Inc.
CSII
| $19M | 3.06% | 484,454 -2,753 | -0.6% | -$108K |
|
15
Xencor
XNCR
$580M
| $18.2M | 2.94% | 467,653 -94,154 | -17% | -$3.67M |
|
16
Halozyme
HALO
$8.56B
| $16.1M | 2.6% | 885,523 -4,206 | -0.5% | -$76.4K |
|
|
XENT
17
DELISTED
Intersect ENT, Inc
XENT
| $14.9M | 2.4% | 517,121 +289,238 | +127% | +$8.32M |
|
18
Codexis
CDXS
$246M
| $14.4M | 2.32% | 837,548 -3,871 | -0.5% | -$66.4K |
|
|
19
Veracyte
VCYT
$2.39B
| $11.3M | 1.83% | 1,187,694 +305,711 | +35% | +$2.92M |
|
|
20
Tandem Diabetes Care
TNDM
$845M
| $11.3M | 1.82% | 263,883 -1,640,377 | -86% | -$70.3M |
|
|
NVTR
21
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $8.42M | 1.36% | 382,908 -337 | -0.1% | -$7.41K |
|
|
KTWO
22
DELISTED
K2M Group Holdings, Inc
KTWO
| $7.93M | 1.28% | 289,756 -2,387 | -0.8% | -$65.3K |
|
23
Dynavax Technologies
DVAX
$1.19B
| $6.77M | 1.09% | 546,265 -2,512 | -0.5% | -$31.2K |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.04M | 0.97% | 62,298 -452 | -0.7% | -$43.8K |
|
25
Globus Medical
GMED
$8.27B
| $5.9M | 0.95% | 103,908 -707 | -0.7% | -$40.1K |
|